Thomas Peter Kalmbach Sells 15,637 Shares of Globe Life (NYSE:GL) Stock

Globe Life Inc. (NYSE:GL) CFO Thomas Peter Kalmbach sold 15,637 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $153.65, for a total transaction of $2,402,625.05. Following the completion of the sale, the chief financial officer directly owned 45,335 shares of the company’s stock, valued at approximately $6,965,722.75. This trade represents a 25.65% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Thomas Peter Kalmbach also recently made the following trade(s):

• On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The shares were sold at an average price of $152.02, for a total transaction of $1,792,315.80.

Globe Life Price Performance

Shares of NYSE:GL opened at $152.87 on Thursday. The company has a 50-day simple moving average of $145.57 and a 200-day simple moving average of $140.89. Globe Life Inc. has a one year low of $116.73 and a one year high of $156.69. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. The stock has a market capitalization of $11.87 billion, a price-to-earnings ratio of 10.57 and a beta of 0.50.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The business had revenue of $1.56 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the previous year, the company posted $3.07 earnings per share. Globe Life’s quarterly revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, analysts predict that Globe Life Inc. will post 15.56 EPS for the current year.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, July 6th. Globe Life’s payout ratio is 9.13%.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. Compound Planning Inc. grew its holdings in Globe Life by 4.3% during the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock worth $275,000 after acquiring an additional 82 shares in the last quarter. Root Financial Partners LLC boosted its holdings in shares of Globe Life by 23.3% in the 1st quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock valued at $61,000 after buying an additional 83 shares during the period. Transcend Capital Advisors LLC boosted its holdings in shares of Globe Life by 3.9% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock valued at $317,000 after buying an additional 84 shares during the period. Natural Investments LLC boosted its holdings in shares of Globe Life by 2.6% in the 4th quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after buying an additional 87 shares during the period. Finally, Parallel Advisors LLC boosted its holdings in shares of Globe Life by 5.6% in the 4th quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after buying an additional 87 shares during the period. 81.61% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have weighed in on GL. JPMorgan Chase & Co. upped their target price on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Wells Fargo & Company increased their price target on shares of Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a research report on Friday, April 10th. Evercore set a $157.00 price objective on shares of Globe Life in a research note on Wednesday, February 18th. Truist Financial raised their target price on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research note on Friday, April 24th. Finally, Weiss Ratings cut shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, April 27th. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $172.67.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.